Eating Disorder :: Binge eating more common than other eating disorders
Binge eating disorder is more prevalent than either anorexia nervosa or bulimia nervosa or other eating disorders, revealed by researchers at Harvard-affiliated McLean Hospital.
People
Red Cross :: American Red Cross urges caution at home
As residents of Central Florida awoke this morning to updated reports of increased devastation in their community, some have begun to start the recovery process.
Red Cross :: American Red Cross mobilizes resources in Central Florida
Deadly storms blew across Central Florida early Friday morning, damaging homes, killing residents and causing power outages.
Cancer :: Black Americans suffer more from cancer
Black people still have a much higher death rate from cancer than whites even though US cancer death rates are down overall and among blacks as well, the American Cancer Society said.
Insulin :: Oral insulin to prevent type 1 diabetes tested
The US National Institutes of Health has started an international study of the use of oral insulin to prevent or delay type 1 diabetes.
Gene :: Gene variant may predict heart disease, stroke
Scientists at Children?s Hospital Oakland Research Institute (CHORI), the University of Iowa and Roche Molecular Systems are the first to identify a new gene variant that makes women more susceptible to developing heart disease.
HIV :: New WHO Chief fails to stand up for people living with AIDS
AIDS Healthcare Foundation says WHO Chief’s lack of support for Thai action on compulsory AIDS drug licensing makes it clear that the health of people living with HIV in Thailand is not among her priorities.
Filter :: Professor wins $1M for arsenic filter
Abul Hussam, an associate professor in the department of chemistry and biochemistry at George Mason University, Fairfax, Va., will receive the Grainger Challenge Gold Award of $1 million for his SONO filter, a household water treatment system.
Psoriasis :: Abbott data shows drug clears psoriasis
Abbott Laboratories said that three out of four patients suffering from psoriasis showed significant improvement when given the anti-inflammation treatment Humira in a late-stage clinical trial.
Von Willebrand Disease :: FDA approves new product to treat Von Willebrand Disease
The U.S. Food and Drug Administration (FDA) announced the approval of Antihemophilic Factor/von Willebrand Factor Complex (Human), Alphanate. The product is approved for patients undergoing surgery or invasive procedures with von Willebrand disease (vWD) in whom the hormone desmopressin is either ineffective or contraindicated.